The plan is finally coming together. Shorts holding 1.64 mil need to start covering. Would like to see the rights to Silenor OTC sold to GSK or bought out altogether. Need to pay off the Treximet notes and the shareholder value will finally be recognized. This was a $119.00 per share company 3 years ago. Double digits are easily attained here in the very near future. Congrats to the patient and GLTA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.